Recommended Medications and Treatment Options for Anxiety
For anxiety disorders, the first-line pharmacological treatments are Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), with cognitive-behavioral therapy (CBT) recommended as a primary non-pharmacological intervention. 1
Pharmacological Treatment Options
First-Line Medications
SSRIs
SNRIs
Second-Line/Adjunctive Medications
Non-benzodiazepine anxiolytics
- Buspirone: Initial dose 5 mg twice daily, maximum 20 mg three times daily
- Takes 2-4 weeks to become effective 1
Benzodiazepines (short-term use only)
Non-Pharmacological Treatment Options
Cognitive-Behavioral Therapy (CBT)
- Structure: 14 sessions over approximately 4 months
- Session duration: 60-90 minutes
- Components:
- Psychoeducation
- Cognitive restructuring
- Gradual exposure to feared situations
- Relapse prevention 1
Lifestyle Interventions
- Regular exercise, particularly in the morning
- Good sleep hygiene
- Limiting screen time before bed
- Spending time in nature
- Mindfulness and meditation practices 1
Treatment Algorithm Based on Severity
Mild Functional Impairment
- Supportive care from primary care team
- Self-help with CBT-based support 1
Moderate to Severe Functional Impairment
- Combination of CBT and SSRI/SNRI
- Regular monitoring of treatment response and side effects 1
Severe Functional Impairment with Treatment Resistance
- Consider altering treatment course after 8 weeks of poor response
- Options include:
- Switching to another SSRI/SNRI
- Adding adjunctive medication
- Intensifying psychotherapy 1
Monitoring and Duration of Treatment
- Assess response after 4-6 weeks of starting medication
- Monitor side effects, particularly during initial treatment phase
- Continue medication for at least 6-12 months after symptom remission
- Taper gradually when discontinuing to avoid withdrawal symptoms 1
Special Considerations
- Elderly patients: Start with lower doses and titrate more slowly
- Hepatic/renal impairment: Use caution with certain medications like paroxetine
- Children and adolescents: SSRIs are first-line but require monitoring for suicidal ideation 1
Common Pitfalls to Avoid
- Abrupt discontinuation of SSRIs, SNRIs, or benzodiazepines can lead to withdrawal symptoms 5
- Long-term benzodiazepine use increases risk of dependence and should be avoided 1, 5
- Inadequate treatment duration - anxiety disorders often require at least 6-12 months of medication after symptom remission 1
- Failure to combine pharmacotherapy with CBT when indicated for moderate to severe cases 1
- Not reassessing treatment efficacy - if no improvement after 8 weeks, treatment plan should be modified 1
By following these evidence-based recommendations, most patients with anxiety disorders can achieve significant symptom improvement and better quality of life.